Objective To investigate the health‐related quality of life (HRQOL) change over time, as
measured by the Child Health Questionnaire (CHQ), and its determinants in patients with …

Objective To compare quality of life in adults diagnosed with juvenile dermatomyositis (DM)
with that of matched controls, and to analyze the association with other disease parameters …

Objective To validate a core set of outcome measures for the evaluation of response to
treatment in patients with juvenile dermatomyositis (DM). Methods In 2001, a preliminary …

Objective Physical disability is perhaps the most important outcome of juvenile
dermatomyositis (JDM). No functional assessment tool has been validated for inflammatory …

Objective To investigate the effects of a supervised exercise training program on health
parameters, physical capacity, and health‐related quality of life in patients with mild and …

Objectives. The aims of this study were to examine disease activity by the Paediatric
Rheumatology International Trials Organization (PRINTO) criteria for inactive disease and …

Background To describe long-term outcomes in JDM using patient questionnaires and link
to longitudinal, prospectively collected data for each patient within the Juvenile …

Juvenile dermatomyositis (JDM) affects two to four children per million. Prior to treatment
with corticosteroids, JDM had a high mortality rate (> 30%) and left 50% of those who …

Objective To develop a provisional definition for the evaluation of response to therapy in
juvenile dermatomyositis (DM) based on the Paediatric Rheumatology International Trials …

Objective. To describe cumulative organ damage in juvenile dermatomyositis (JDM) patients
and to identify patient characteristics and early disease variables that predict organ damage …